231 related articles for article (PubMed ID: 16474069)
1. High titers of IgG antibodies against Plasmodium falciparum serine repeat antigen 5 (SERA5) are associated with protection against severe malaria in Ugandan children.
Okech B; Mujuzi G; Ogwal A; Shirai H; Horii T; Egwang TG
Am J Trop Med Hyg; 2006 Feb; 74(2):191-7. PubMed ID: 16474069
[TBL] [Abstract][Full Text] [Related]
2. Pigmented monocytes are negative correlates of protection against severe and complicated malaria in Ugandan children.
Mujuzi G; Magambo B; Okech B; Egwang TG
Am J Trop Med Hyg; 2006 May; 74(5):724-9. PubMed ID: 16687669
[TBL] [Abstract][Full Text] [Related]
3. Evidences of protection against blood-stage infection of Plasmodium falciparum by the novel protein vaccine SE36.
Horii T; Shirai H; Jie L; Ishii KJ; Palacpac NQ; Tougan T; Hato M; Ohta N; Bobogare A; Arakaki N; Matsumoto Y; Namazue J; Ishikawa T; Ueda S; Takahashi M
Parasitol Int; 2010 Sep; 59(3):380-6. PubMed ID: 20493274
[TBL] [Abstract][Full Text] [Related]
4. Plasmodium falciparum serine repeat antigen 5 (SE36) as a malaria vaccine candidate.
Palacpac NM; Arisue N; Tougan T; Ishii KJ; Horii T
Vaccine; 2011 Aug; 29(35):5837-45. PubMed ID: 21718740
[TBL] [Abstract][Full Text] [Related]
5. Antibody responses to a panel of Plasmodium falciparum malaria blood-stage antigens in relation to clinical disease outcome in Sudan.
Iriemenam NC; Khirelsied AH; Nasr A; ElGhazali G; Giha HA; Elhassan A-Elgadir TM; Agab-Aldour AA; Montgomery SM; Anders RF; Theisen M; Troye-Blomberg M; Elbashir MI; Berzins K
Vaccine; 2009 Jan; 27(1):62-71. PubMed ID: 18977268
[TBL] [Abstract][Full Text] [Related]
6. Antibody response profiles induced by Plasmodium falciparum glutamate-rich protein in naturally exposed individuals from a Brazilian area endemic for malaria.
Pratt-Riccio LR; Lima-Junior JC; Carvalho LJ; Theisen M; Espíndola-Mendes EC; Santos F; Oliveira-Ferreira J; Goldberg AC; Daniel-Ribeiro CT; Banic DM
Am J Trop Med Hyg; 2005 Dec; 73(6):1096-103. PubMed ID: 16354819
[TBL] [Abstract][Full Text] [Related]
7. Correlation of high levels of antibodies to multiple pre-erythrocytic Plasmodium falciparum antigens and protection from infection.
John CC; Moormann AM; Pregibon DC; Sumba PO; McHugh MM; Narum DL; Lanar DE; Schluchter MD; Kazura JW
Am J Trop Med Hyg; 2005 Jul; 73(1):222-8. PubMed ID: 16014863
[TBL] [Abstract][Full Text] [Related]
8. Association of naturally acquired IgG antibodies against Plasmodium falciparum serine repeat antigen-5 with reduced placental parasitemia and normal birth weight in pregnant Ugandan women: a pilot study.
Owalla TJ; Palacpac NM; Shirai H; Horii T; Egwang TG
Parasitol Int; 2013 Jun; 62(3):237-9. PubMed ID: 23395684
[TBL] [Abstract][Full Text] [Related]
9. Do antibody responses to malaria vaccine candidates influenced by the level of malaria transmission protect from malaria?
Nebie I; Tiono AB; Diallo DA; Samandoulougou S; Diarra A; Konate AT; Cuzin-Ouattara N; Theisen M; Corradin G; Cousens S; Ouattara AS; Ilboudo-Sanogo E; Sirima BS
Trop Med Int Health; 2008 Feb; 13(2):229-37. PubMed ID: 18304269
[TBL] [Abstract][Full Text] [Related]
10. Antibodies elicited by a virosomally formulated Plasmodium falciparum serine repeat antigen-5 derived peptide detect the processed 47 kDa fragment both in sporozoites and merozoites.
Okitsu SL; Boato F; Mueller MS; Li DB; Vogel D; Westerfeld N; Zurbriggen R; Robinson JA; Pluschke G
Peptides; 2007 Oct; 28(10):2051-60. PubMed ID: 17875342
[TBL] [Abstract][Full Text] [Related]
11. Distribution of IgG subclass antibodies specific for Plasmodium falciparum glutamate-rich-protein molecule in sickle cell trait children with asymptomatic infections.
Matondo Maya DW; Mavoungou E; Deloron P; Theisen M; Ntoumi F
Exp Parasitol; 2006 Feb; 112(2):92-8. PubMed ID: 16356497
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal analyses of immune responses to Plasmodium falciparum derived peptides corresponding to novel blood stage antigens in coastal Kenya.
Agak GW; Bejon P; Fegan G; Gicheru N; Villard V; Kajava AV; Marsh K; Corradin G
Vaccine; 2008 Apr; 26(16):1963-71. PubMed ID: 18342997
[TBL] [Abstract][Full Text] [Related]
13. IgE antibodies to Plasmodium falciparum and severity of malaria in children of one ethnic group living in Burkina Faso.
Calissano C; Modiano D; Sirima BS; Konate A; Sanou I; Sawadogo A; Perlmann H; Troye-Blomberg M; Perlmann P
Am J Trop Med Hyg; 2003 Jul; 69(1):31-5. PubMed ID: 12932093
[TBL] [Abstract][Full Text] [Related]
14. Differential regulation of IgG subclasses and IgE antimalarial antibody responses in complicated and uncomplicated Plasmodium falciparum malaria.
Tangteerawatana P; Montgomery SM; Perlmann H; Looareesuwan S; Troye-Blomberg M; Khusmith S
Parasite Immunol; 2007 Sep; 29(9):475-83. PubMed ID: 17727571
[TBL] [Abstract][Full Text] [Related]
15. Naturally acquired antibodies to the glutamate-rich protein are associated with protection against Plasmodium falciparum malaria.
Dodoo D; Theisen M; Kurtzhals JA; Akanmori BD; Koram KA; Jepsen S; Nkrumah FK; Theander TG; Hviid L
J Infect Dis; 2000 Mar; 181(3):1202-5. PubMed ID: 10720556
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity and in vitro protective efficacy of a polyepitope Plasmodium falciparum candidate vaccine constructed by epitope shuffling.
Cai Q; Peng G; Bu L; Lin Y; Zhang L; Lustigmen S; Wang H
Vaccine; 2007 Jul; 25(28):5155-65. PubMed ID: 17548134
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
Lalitha PV; Biswas S; Pillai CR; Saxena RK
Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786
[TBL] [Abstract][Full Text] [Related]
18. Natural antibody response to Plasmodium falciparum Exp-1, MSP-3 and GLURP long synthetic peptides and association with protection.
Meraldi V; Nebié I; Tiono AB; Diallo D; Sanogo E; Theisen M; Druilhe P; Corradin G; Moret R; Sirima BS
Parasite Immunol; 2004; 26(6-7):265-72. PubMed ID: 15541030
[TBL] [Abstract][Full Text] [Related]
19. Antibody responses to several malaria pre-erythrocytic antigens as a marker of malaria exposure among travelers.
Orlandi-Pradines E; Penhoat K; Durand C; Pons C; Bay C; Pradines B; Fusai T; Josse R; Dubrous P; Meynard JB; Durand JP; Migliani R; Boutin JP; Druilhe P; Rogier C
Am J Trop Med Hyg; 2006 Jun; 74(6):979-85. PubMed ID: 16760507
[TBL] [Abstract][Full Text] [Related]
20. Protection against clinical malaria by heterologous immunoglobulin G antibodies against malaria-infected erythrocyte variant surface antigens requires interaction with asymptomatic infections.
Kinyanjui SM; Mwangi T; Bull PC; Newbold CI; Marsh K
J Infect Dis; 2004 Nov; 190(9):1527-33. PubMed ID: 15478055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
